Los glucocorticoides y el rendimiento deportivo

2003 Goodman, 2003 Rodés, 2002 Ardite, 1998, Effects of steroid treatment on activation of nuclear factor kappa B in patients with inflammatory bowel disease, Br J Pharmacol, 124, 431, 10.1038/sj.bjp.0701887 Panes, 1999, Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention, Br J Pharmacol, 126, 537, 10.1038/sj.bjp.0702328 Sigal, 1994 Rodés, 2004 Belvisi, 2003, Soft steroids: a new approach to the treatment of inflammatory airways diseases, Pulmonary Pharmacol Therapeutics, 16, 321, 10.1016/S1094-5539(03)00105-6 Van Cauwenberge, 2005, Glucocorticosteroids in allergic inflammation: clinical benefits in allergic rhinitis, rhinosinusitis, and otitis media, Immunol Allergy Clin North Am, 25, 489, 10.1016/j.iac.2005.05.001 Cameron, 2001, Regulation of allergic airways inflammation by cytokines and glucocorticoids, Curr Allergy Asthma Rep, 1, 153, 10.1007/s11882-001-0083-6 Sadowska, 2005, Inhibition of in vitro neutrophil migration through a bilayer of endothelial and epithelial cells using beta2-agonists: concomitant effects on IL-8 and elastase secretion and impact of glucocorticosteroids, Pulmonary Pharmacol Therapeutics, 18, 354, 10.1016/j.pupt.2005.01.006 Shephard, 1998, Immune responses to inflammation and trauma: a physical training model, Can J Physiol Pharmacol, 76, 469, 10.1139/y98-048 Boushel, 2004, Regulation of blood flow by prostaglandins, Curr Vasc Pharmacol, 2, 191, 10.2174/1570161043476410 Rochcongar, 2005, L’utilisation et la prescription des corticoides en médecine du sport, Sci Sports, 20, 197, 10.1016/j.scispo.2005.01.025 Ines, 2005, Soft tissue injections, Best Practice Res Clin Rheumatol, 19, 503, 10.1016/j.berh.2005.01.003 Assendelft, 1996, Corticosteroid injections for lateral epicondylitis: a systematic overview, Br J Gen Pract, 46, 209 Hay, 1999, Pragmatic randomized controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care, BMJ, 319, 964, 10.1136/bmj.319.7215.964 Speed, 2003, Injection therapies for Soft tissue disorders, Best Practice Res Clin Rheumatol, 17, 167, 10.1016/S1521-6942(02)00122-5 Rochcongar, 2004, L’utilisation et la prescription des corticoïdes en médecine du sport, Sci Sports, 19, 145, 10.1016/j.scispo.2004.03.002 Marquet, 1995, Effets de la dexaméthasone chez le sujet sain à l’effort. Paramètres bioénergétiques et cardiovasculaires. Hormones et métabolisme hydrominéral, Sci Sports, 10, 67, 10.1016/0765-1597(96)89529-3 Marquet, 1999, Dexamethasone in resting and exercising men. I. Effects on bioenergetics, minerals, and related hormones, J Appl Physiol, 87, 175, 10.1152/jappl.1999.87.1.175 Lac, 1999, Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones, J Appl Physiol, 87, 183, 10.1152/jappl.1999.87.1.183 Viru, 1982, Independence of physical working capacity from increased glucocorticoid level during short-term exercises, Int J Sports Med, 3, 80, 10.1055/s-2008-1026067 Manohar, 2002, Anti-inflammatory agent, dexamethasone, does not affect exercise-induced arterial hypoxemia in Thoroughbreds, J Appl Physiol, 93, 99, 10.1152/japplphysiol.01186.2001 Deuster, 1999, Expression of lymphocyte subsets after exercise and dexamethasone in high and low stress responders, Med Sci Sports Exerc, 31, 1799, 10.1097/00005768-199912000-00016 Deuster, 2000, Endocrine response to high-intensity exercise: dose-dependent effects of dexamethasone, J Clin Endocrinol Metab, 85, 1066, 10.1210/jc.85.3.1066 Córdova, 2003